Follow on Google News News By Tag * Gen * Genetic Engineering Biotechnology News * Cryptogram Challenge * Elisa Plate * Scintellix * Invitrogen * Gen Contest * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Take GEN’s Cryptogram Challenge for Your Chance to Win $1,500If you like solving puzzles and are looking to test your genius, Genetic Engineering & Biotechnology News' (GEN) latest contest will stimulate your brain.
By: Genetic Engineering & Biotechnology News Take GEN’s Cryptogram Challenge for Your Chance to Win $1,500 New Rochelle, NY—If you like solving puzzles and are looking to test your genius, GEN’s latest contest will stimulate your brain. Based on the success of the Microarray Challenge, which ran late last year, Genetic Engineering & Biotechnology News (GEN), Scintellix, LLC, and Invitrogen, part of Life Technologies Corporation, are proud to bring you the Cryptogram Challenge. To take a stab at the Cryptogram Challenge, go to: http://www.genengnews.com/ “The fabulous response we received from the Microarray Challenge drove the decision for GEN and Scintellix to extend their partnership in creating additional thought-provoking puzzles,” says Joan Boyce, group publisher for GEN. “GEN is very excited to be working with Dr. Peter Johnson on this new Cryptogram Challenge that promises to be equally demanding and a fun experience for all who participate.” Peter C. Johnson, M.D., President and CEO of Scintellix, has hidden a message in a 96-well image based on the color of each well. The first contestant to decode the cipher will be featured in a future issue of GEN and receive $1,500. The first 150 registrants will receive a T-shirt depicting the cryptogram. The challenge requires not only skill and scientific experience to crack but also a strong appreciation for biological studies. “96 Well was created to convey both the beauty of the ELISA plate and the power of its retained information by encoding within it a powerful message using a specific cryptographic technique,” points out Dr. Johnson. The contest begins today, September 1, and will close once the puzzle is solved. Here’s the first clue to help you out: The code reads left to right. We will supply clues every week to nudge you in the right direction. Contestants can submit as many entries as they like up to once a per day. Dr. Johnson will be the judge, and a sealed solution will be held in escrow. About the Partnership GEN and Scintellix have formed a partnership to explore the hidden meaning found in biological imagery. The Cryptogram Challenge is the second installment of the partnership. For more information, go to: www.genengnews.com/ About GEN Genetic Engineering & Biotechnology News (GEN) was introduced in 1981 as the first biotechnology trade publication. Published 21 times a year, GEN still retains its position as the most widely read biotechnology publication around the globe. Its unique news and technology content focus includes the entire bioproduct life cycle from early-stage R&D to applied research including omics, biomarkers, as well as diagnostics to bioprocess and through to commercialization. For more information, go to: http://www.genengnews.com About Scintellix, LLC Scintellix, LLC applies decision analysis methodologies to support the resolution of complex problems in personal and corporate development. The company is located in Raleigh, NC. For more information, go to: www.scintellix.com About Life Technologies Life Technologies Corporation is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables, and services enable researchers to accelerate scientific exploration, leading to discoveries and developments that make life even better. Life Technologies’ Genetic Engineering & Biotechnology News 140 Huguenot St New Rochelle, NY 10801, USA http://www.genengnews.com # # # Genetic Engineering & Biotechnology News (GEN) was introduced in 1981 as the first biotechnology trade publication. Published 21 times a year by Mary Ann Liebert, INc., GEN still retains its position as the most widely read biotechnology publication around the globe. Its unique news and technology content focus includes the entire bioproduct life cycle from early-stage R&D to applied research including omics, biomarkers, as well as diagnostics to bioprocess and through to commercialization. For more information, go to: www.genengnews.com End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
